IAC Nuclear/PET - Newsroom

ASNC, IAC and SNMMI Call for Field to Focus on Radiation Dose Optimization in Nuclear Cardiology

NOVEMBER 2016 | Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal Accreditation Commission (IAC)’s Nuclear/PET accreditation division and the Society of Nuclear Medicine in Molecular Imaging (SNMMI) are mandating optimized radiation doses in conjunction with the nuclear cardiology studies Joint Logo SNMMI ASNC (i.e., myocardial perfusion imaging) performed throughout the United States and beyond.

These efforts come in response to recently published research1,2 demonstrating that adherence to clinical nuclear imaging guidelines for reduced patient radiation exposure is variably implemented, resulting in administration of higher doses than necessary for some patients undergoing myocardial perfusion studies.

In February 2016, ASNC published guidelines for myocardial perfusion SPECT imaging, ASNC Imaging Guidelines for SPECT Nuclear Cardiology Procedures: Stress Protocols and Tracers, which include a chart entitled “Current SPECT Myocardial Perfusion Imaging Protocols: Recommended Radiopharmaceutical Activities and Their Corresponding Radiation Effective Doses.” These recommendations provide guidance for practitioners and are based on ASNC’s guiding principle of performing the most appropriate study that provides the highest quality data to aid in medical decision-making and minimizes risks to patients. Dose reduction strategies based on weight-based radiotracer dosing, thoughtful selection of radiotracer, stress-only imaging when appropriate, software innovations, state-of-the-art SPECT systems and utilization of PET for myocardial perfusion imaging are all methods supported by ASNC to achieve quality cardiac imaging at the lowest radiation exposure.

Read the complete press release»

IAC Releases Updates to Nuclear/PET Standards - New Standards Effective March 15, 2017

As an accreditation organization, IAC Nuclear/PET is committed to maintaining a program that balances the changing needs of both the nuclear cardiology, nuclear medicine and PET community and the general public by influencing the quality of patient care provided. The IAC Standards and Guidelines for Nuclear/PET Accreditation are the most important component of that commitment. Composed by physicians and technologists from the IAC sponsoring organizations, the Standards are reviewed periodically by the Board of Directors and revised as needed.

As a component of the accreditation process, the IAC Nuclear/PET Board of Directors preliminarily approved the proposed Standards which were posted to the IAC Nuclear/PET website for a 60-day public comment period from April 1 to June 1, 2016. Following careful review and consideration of the comments received, the Board of Directors voted final approval of the Standards.

Access the Standards

View the new IAC Standards and Guidelines for Nuclear/PET Accreditation on the website:

Download: The IAC Standards and Guidelines for Nuclear/PET Accreditation

Standards that are highlighted are major content changes that were made as part of the September 15, 2016 revision. These Standards will become effective on March 15, 2017. Facilities applying for accreditation after March 15, 2017 must comply with these new highlighted Standards.

Key Revisions to the IAC Standards for Nuclear/PET

Some of the changes made are a clarification or explanation of the previous Standards, however, in several instances, the requirements have been modified. Key modifications include:

  • Technical Staff - The Standard previously titled nuclear medicine technologist(s) is now technical staff in all references.
  • General Protocol Guidelines - A substantial change to the IAC Nuclear/PET Standards regarding the required administered radiopharmaceutical dose ranges and corresponding radiation effective doses for myocardial perfusion imaging was made. To read the background on this change, please visit intersocietal.org/nuclear/main/dose.htm.
  • Part D: Therapy Procedures - The majority of the new Part D section already existed in the previous Standards, however, these requirements were moved to a new section for Therapy Protocols and Performance only.

For a summary of all the revisions made to the Nuclear/PET Standards, please visit intersocietal.org/nuclear/standards/IACNuclearPETStandards2016_SummaryofChanges.pdf.

Proposed Changes to IAC Nuclear/PET Standards Now Open for Public Comment - THIS COMMENT PERIOD IS NOW CLOSED

APRIL 1, 2016 | In keeping with the IAC's continued commitment to streamlining and simplifying the accreditation process, we are pleased to announce that the public now has the opportunity to comment on proposed changes to the IAC Standards and Guidelines for Nuclear/PET Accreditation

A substantial change to the IAC Nuclear/PET Standards regarding the required radiopharmaceutical activities and their corresponding radiation effective doses is proposed. To read background on this change, please visit intersocietal.org/nuclear/main/dose.htm.

The Standards are reviewed periodically by the IAC Nuclear/PET Board of Directors and revised as needed. As a component to the accreditation process, proposed Standards that have been approved by the Board of Directors are then posted to the IAC website for a 60-day public comment period. These proposed Standards include changes to the current Standards, the removal of current Standards and/or the addition of new Standards

Beginning April 1st, 2016, the public may visit the IAC website at intersocietal.org/iac/comment_period.htm to comment on any of the proposed Standards until June 1st, 2016. In order to provide comments, the IAC Comment Form must be completed and submitted electronically by the provided deadline.

To Submit a Comment on Proposed Standards:

  1. Visit the IAC website at intersocietal.org/iac/comment_period.htm;
  2. Select the proposed Nuclear/PET Standard on which to comment;
  3. A window will expand with the description of the Standard and the proposed change on the left;
  4. On the right, fill in your name and comment in the boxes provided; 
  5. Hit Submit.

At the close of the comment period, the IAC Nuclear/PET Board of Directors will review any submitted comments, consider modifications as needed and vote for final approval of the Standards. Facilities are notified of changes to the published Standards, and the most current version of the Standards can be viewed or printed from the IAC Nuclear/PET website at intersocietal.org/nuclear/main/nuclear_standards.htm.

IAC Announces New Chief Executive Officer

FEBRUARY 29, 2016 | The Intersocietal Accreditation Commission (IAC) announces that their Board of Directors has appointed Mary Lally, MS, CAE, as Chief Executive Officer. IAC 25th LogoAs CEO, Ms. Lally succeeds Sandra Katanick, retiring as IAC’s founding CEO since 1991.

“We are pleased to announce this appointment,” said Raymond Stainback, MD, FACC, FASE. IAC Chairperson. “Mary will bring leadership and clinical expertise to this important role. Having served the IAC for more than eight years, she has demonstrated her skills through programmatic and leadership development. She brings a wealth of perspective and experience.”

Bringing to the position a unique combined background of clinical expertise and association management experience, Ms. Lally possesses both a Master’s degree in Radiation Health Physics as well as the Certified Association Executive (CAE) credential.

Read the complete press release»

News Archive (Articles Prior to 2016)

2015 (click on the article name to view PDF)

2014 (click on the article name to view PDF)

2013 (click on the article name to view PDF)

2012 (click on the article name to view PDF)

2011 (click on the article name to view PDF)

2010 (click on the article name to view PDF)